Improved accuracy of supervised CRM discovery with interpolated Markov models and cross-species comparison by Kazemian, Majid et al.
Improved accuracy of supervised CRM discovery
with interpolated Markov models and
cross-species comparison
Majid Kazemian
1, Qiyun Zhu
2, Marc S. Halfon
2,3,* and Saurabh Sinha
1,4,*
1Department of Computer Science, University of Illinois at Urbana-Champaign, Urbana, IL 61801,
2Department
of Biological Sciences,
3Department of Biochemistry and NY State Center of Excellence in Bioinformatics &
Life Sciences, SUNY-University at Buffalo, NY 14260 and
4Institute for Genomic Biology, University of Illinois at
Urbana-Champaign, Urbana, IL 61801, USA
Received April 27, 2011; Revised July 12, 2011; Accepted July 16, 2011
ABSTRACT
Despite recent advances in experimental approa-
ches for identifying transcriptional cis-regulatory
modules (CRMs, ‘enhancers’), direct empirical dis-
covery of CRMs for all genes in all cell types and
environmental conditions is likely to remain an
elusive goal. Effective methods for computational
CRM discovery are thus a critically needed comple-
ment to empirical approaches. However, existing
computational methods that search for clusters of
putative binding sites are ineffective if the relevant
TFs and/or their binding specificities are unknown.
Here, we provide a significantly improved method
for ‘motif-blind’ CRM discovery that does not de-
pend on knowledge or accurate prediction of
TF-binding motifs and is effective when limited know-
ledge of functional CRMs is available to ‘supervise’
the search. We propose a new statistical method,
based on ‘Interpolated Markov Models’, for motif-
blind, genome-wide CRM discovery. It captures the
statistical profile of variable length words in known
CRMs of a regulatory network and finds candidate
CRMs that match this profile. The method also uses
orthologs of the known CRMs from closely related
genomes. We perform in silico evaluation of pre-
dicted CRMs by assessing whether their neighbor-
ing genes are enriched for the expected expression
patterns. This assessment uses a novel statistical
test that extends the widely used Hypergeometric
test of gene set enrichment to account for variability
in intergenic lengths. We find that the new CRM pre-
diction method is superior to existing methods.
Finally, we experimentally validate 12 new CRM pre-
dictions by examining their regulatory activity in vivo
in Drosophila; 10 of the tested CRMs were found to
be functional, while 6 of the top 7 predictions
showed the expected activity patterns. We make
our program available as downloadable source
code, and as a plugin for a genome browser in-
stalled on our servers.
INTRODUCTION
Temporal and spatial regulation of gene expression results
from the interaction of transcription factors (TFs) with
speciﬁc cis-regulatory DNA sequences. These regulatory
sequences are typically organized in a modular fashion
with each module containing one or more binding sites for
a speciﬁc combination of TFs (1). A ‘cis-regulatory module’
(CRM) can thus be deﬁned as a collection of TF-binding
sites that function jointly to regulate a discrete aspect of a
gene’s expression pattern. CRMs are generally described
as being short (<1000bp) contiguous stretches of DNA,
located few to hundreds of kilobases away from their as-
sociated gene, and are found ﬁve-prime, three-prime and
within introns of the gene. Davidson (2) estimates that
there may be as many as 10-fold more CRMs than genes,
yet the vast majority of CRMs have not been identiﬁed.
The problem of CRM discovery is complicated by the fact
that unlike protein-coding regions, which have recogniz-
able sequence features such as open reading frames and
codon-usage biases, no similar properties are known for
CRMs; and unlike promoters, which by deﬁnition lie imme-
diately ﬁve-prime to the gene and which contain a limited
number of well-deﬁned sequence motifs (3), CRMs are
constrained neither in location nor by motif composition.
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lves a tedious process of testing many sequence fragments
for regulatory activity in a reporter gene assay. Recently
developed genomic techniques have led to relatively rapid
screens for potential gene-regulatory regions; such tech-
niques include chromatin immunoprecipitation coupled
to genomic tiling arrays (ChIP-chip) (4) and ultra high-
throughput sequencing (ChIP-Seq) (5). Despite their great
promise, these empirical methods have limitations: it is
currently infeasible to assay all tissue types under all con-
ditions, and potential CRMs may be missed by these tech-
niques. In recent years, computational methods have
provided an attractive alternative for module identiﬁca-
tion. Computational methods (6–11) typically start with
a small set of relevant TFs and their binding motifs, and
search the genome for clusters of putative binding sites
(motif matches). However, this approach is ineffective if
the relevant TFs and/or their binding speciﬁcities are
unknown. Motif databases for Drosophila currently cata-
log only a fraction of the estimated number of TFs
(12–14). Intense efforts are being made to characterize
TF-binding speciﬁcities in mouse and ﬂy (15,16), but
these efforts are labor intensive and expensive, and the
problem of sparse motif knowledge may thus persist for
scientists studying organisms other than human, mouse
and fruit ﬂy. Moreover, for the majority of regulatory
systems, some or most of the relevant TFs have not yet
been identiﬁed. For these reasons, the application of
motif-based computational methods has been limited to
a few well-understood biological systems, where the neces-
sary prior knowledge is available. Specialized computa-
tional tools to discover motifs from the training data
may alleviate the problem, but the modest success rate
of motif ﬁnding programs (especially for metazoan gen-
omes), as suggested by past surveys (17–19), casts doubts
upon the prospect of CRM discovery based on computa-
tional motif ﬁnding.
This article examines CRM prediction in the common
scenario where knowledge of the relevant TFs and/or their
binding speciﬁcities (motifs) is missing. In particular, we
ask the following question: suppose a small set of modules
participating in a transcriptional network is known a
priori. Can we use such information as ‘training data’ to
guide the search for other modules in that network? We
call this task the ‘supervised CRM prediction problem’.
The success of a CRM prediction may be deﬁned as the
ability of the predicted sequence to drive a discrete
temporal and/or spatial expression pattern. An additional,
stricter criterion for success is that the predicted CRM
recapitulates the common expression pattern of the
training CRMs.
Here, we undertake supervised CRM discovery without
assuming motif knowledge or the ability to accurately
discover the relevant motifs ab initio. In a previous publi-
cation (20), we proposed various statistics to capture the
sequence similarity (due to shared TF-binding sites) be-
tween a candidate CRM and the training set of modules.
Our study included previously reported approaches to the
problem (21,22) as well as some new statistical techniques.
We demonstrated that these techniques could then be used
effectively to discover CRMs in Drosophila and human
genomes. Narlikar and colleagues (23) used a similar ap-
proach to predict human heart enhancers. Here, we ad-
vance the state-of-the-art in solving this problem by
developing a new statistical approach that improves sig-
niﬁcantly upon previous methods. This new score is based
on ‘interpolated Markov models’ (IMM) and the use of
multi-species comparison. An IMM can be thought of as a
combination of Markov chains of varying orders, and
considers the frequencies of words of variable length in
learning a generative probabilistic model from the training
CRMs. We train an IMM on the training set of CRMs
from D. melanogaster as well as their orthologs from other
Drosophila species, and use the likelihood ratio of this
model and a suitable null model as the score of a candi-
date CRM. The new method is shown to be superior to
existing techniques in terms of predictive accuracy, which
is assessed using a new statistical test that extends the
widely used Hypergeometric test to correct for an import-
ant bias present in this test as applied to our setting.
We experimentally validated 12 new CRM predictions by
examining their regulatory activity in vivo,a n df o u n d1 0o f
these to be functional. Moreover, we observed that the new
IMM score can effectively discriminate CRMs whose
regulatory activity matches that of the training set from
sequences that either do not drive expression or drive an
expression pattern different from that of the training set.
The new CRM prediction method and evaluation strat-
egy developed here are made publicly available at http://
veda.cs.uiuc.edu/scrm-2/. The method can also be applied
on the Drosophila genome through an online genome
browser interface (http://veda.cs.uiuc.edu/gs, plugin
‘Supervised CRM Discovery’).
MATERIALS AND METHODS
Data sets
The CRM training sets were obtained from (24). The
corresponding expression gene sets were taken from
Supplementary Table S10 in (20) (see Methods in
Supplementary Data for more details). Both training sets
and expression gene sets are publically available at: http://
veda.cs.uiuc.edu/scrm-2/.
IMM-based score
We implemented the IMM introduced by (25) for ﬁnding
microbial genes. Let S={s1, s2,..., sN} be a sequence of
length N. For an nth-order IMM, the conditional prob-
ability of generating si given its preceding context (of n
characters), is:
IMMn si si 1,...,si n j ðÞ ¼  n si 1,...,si n ðÞ Pr si si 1,...,si n j ðÞ
+1   n si 1,...,si n ðÞ ðÞ IMMn 1 si si 1,...,si n+1 j ðÞ
ð1Þ
Here, Pr si si 1,...,si n j ðÞ is proportional to the frequency
of the word si n,...,si 1,si ðÞ in training data and
 n si 1,...,si n ðÞ is a ‘mixture weight’ that depends on
the number of occurrences of the word si n, ...,si 1 ðÞ in
the training data [ 0 ¼ 1; see (25) for details]. Thus,
IMMn si si 1,...,si n j ðÞ is modeled as a mixture over n
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conditioned on a context of a different length (0, 1,..., n).
We score every candidate CRM S using the log likeli-
hood score deﬁned as:
score S ðÞ ¼ log
pSIMM+
5
  
pSIMM 
5
   ð2Þ
where IMM+
5 and IMM 
5 are two 5th-order IMMs trained
on positive and negative sequences, respectively. The
training set was used as positive sequences (both strands
were used for training the model while ignoring the stat-
istical dependencies between the strands), while the nega-
tive sequences used were regions of non-coding genomic
sequence with G/C content similar to the native ﬂanks of
the CRMs. The training data set is publicly available at:
http://veda.cs.uiuc.edu/scrm-2/
Multi-species scoring scheme
Given a training set of CRMs from D. melanogaster,w e
obtained orthologous sequences of each CRM from 10
other Drosophila species using the lift Over program from
the UCSC Genome Browser database, and treated the
resulting set of CRMs as the sequence data on which the
model (IMM or HexMCD) was trained (see Methods in
Supplementary Data). Fewer than 4% of the CRMs were
missing an ortholog in one or more species, which elimin-
ates any potential bias toward CRMs for which more
species are alignable.
Locus length-aware Hypergeometric test
A signiﬁcance test of overlap between two gene sets is trad-
itionally performed with the Hypergeometric test. However,
this test assumes that every gene is equally likely to be
selected a priori. This assumption is not true for the ‘pre-
dicted gene set’ in our setting, which is the set of genes
nearest to predicted CRMs, since gene loci vary in length
across the genome (26). We conﬁrmed that such variation
in locus lengths is true for our data sets (Supplementary
Figure S1A). We designed the ‘locus length-aware
Hypergeometric test’ (LLHT) to correct for this bias.
Our key idea is to assign to each gene a prior probability
of being sampled, in proportion to its locus length. Other
than this modiﬁcation, the LLHT calculations are identi-
cal to the Hypergeometric test. We compared evaluation
P-values obtained using LLHT with those based on the
Hypergeometric test, and found the former to be notice-
ably more conservative for most of the 33 data sets
(Supplementary Figure S1B). We also undertook a
simulation-based experiment to assess the speciﬁcity of
the two tests, and found that the Hypergeometric test is
highly susceptible to false positives when the gene set has
atypical locus lengths, while the LLHT retains its high
speciﬁcity in this scenario (Supplementary Table S1).
Drosophila reporter constructs and transgenic analysis
Genomic sequences were generated by PCR and con-
ﬁrmed by sequencing; genome coordinates for pre-
dicted and tested CRMs are provided in Supplementary
Table S2. The putative CRM sequences were subcloned
into plasmid pattBnucGFPs, a fC31-enabled Drosophila
transformation vector containing EGFP under the control
of a minimal hsp70 promoter (details available on request).
Transgenic ﬂies were produced by Genetic Services Inc.
(Cambridge, MA, USA) by injection into line attP2.
Homozygous transgenic embryos were collected, ﬁxed
and stained with antibodies to GFP (Abcam, ab290)
using standard methods. Muscle expression was visualized
using anti-Tropomyosin (Babraham, MAC 141). DIC mi-
croscopy was performed using a Zeiss Axioplan micro-
scope with a Retiga-EXi camera (Qimaging) and
Openlab software (Improvision). Fluorescent images
were acquired using a Leica SP2 confocal microscope.
All images were color corrected and contrast adjusted in
Adobe Photoshop.
RESULTS AND DISCUSSION
The problem
Suppose we are given a set T of CRMs (called the ‘training
set’) that are known to drive similar expression patterns.
For example, these could be CRMs that regulate genes
with early mesodermal expression or genes that are invo-
lved in wing development. The task is to search the genome
for other CRMs that drive an expression pattern similar to
those in the training set T. A successful method to perform
this task will capture the cis-regulatory signatures of TFs
regulating T, and search genome wide for occurrences of
those signatures. A predicted CRM can be validated by
testing its function in a reporter gene assay and judging if
its expression pattern is similar to that of the training set.
We refer to the task just deﬁned as the ‘supervised CRM
prediction’ problem. Note that the problem is not com-
pletely speciﬁed in this formulation, since we do not pre-
cisely lay down what ‘similarity of expression pattern’
means. Instead, we allow the domain specialist to deter-
mine which characteristics of an expression pattern are
used to deﬁne T and to judge the success of a prediction.
One simple way to deﬁne T (in Drosophila) is to search the
REDﬂy CRM database (27) with speciﬁc expression
terms, such as ‘mesoderm’ or ‘wing’, thereby retrieving
CRMs that have been shown to drive expression in the
mesoderm or wing of the ﬂy, respectively.
It is possible that a predicted CRM upon experimental
testing shows regulatory activity in agreement with a
neighboring gene’s expression pattern, but this regulatory
activity does not match that of the training set T. This is
possible if TFs regulating the training set pleiotropically
participate in a different regulatory network; the CRM
prediction method may correctly learn the cis-regulatory
signatures of such TFs and correctly identify a CRM that
has those signatures, but the CRM may belong to the
second network and hence show activity that does not
match the training set. In cognizance of the above possi-
bility, we deﬁne a second alternative criterion for a suc-
cessful prediction: a CRM that drives an expression
pattern matching that of a neighboring gene. In our ex-
perimental evaluations, we will examine success rates for
prediction using both criteria introduced here.
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An obvious approach to supervised CRM prediction is to
scan the genomic sequence with a shifting window of ﬁxed
size, and score the window for similarity to the training set
of CRMs. The crucial aspect of this approach is the
scoring system for matching a candidate module (‘test
CRM’) to the training set. Different scoring systems
have been proposed in the past, as reviewed and evaluated
in our previous work (20). All of these scores have been
based on comparing the frequencies of short words
(henceforth called ‘k-mers’) between the test CRM and
the training set. This is a reasonable strategy, since the
regulatory function of CRMs is believed to be encoded
in the types and numbers of transcription factor-binding
sites. Speciﬁcally, binding sites that occur repeatedly in the
training CRMs ought to cause some level of overrepre-
sentation of speciﬁc k-mers, and the occurrence of such
words in the test CRM should then indicate functional
similarity. The kinds of scores that have been explored
in this context include Markov chain-based scores (22),
dot product-based scores (28), scores based on Poisson
statistics (29) and others (30,31). For statistical conveni-
ence, these scores have been based on frequencies of
k-mers of a ﬁxed length (chosen from the range 5 to 8).
However, in reality, the recognition motifs of different
TFs are of varying lengths and binding sites of the same
TF are known to display some amount of variability in
sequence. For these reasons, the use of ﬁxed length k-mers
in the statistical scores may be problematic. While longer
k-mers might reﬂect the binding site pattern more accur-
ately, they may not have the statistical support neces-
sary for robust testing, due to the variability among
sites. Moreover, a CRM comprises binding sites of differ-
ent TFs, with varying lengths, further undermining the use
of ﬁxed length k-mers in capturing the overall binding
site composition of the training set. One natural solution
to this problem is to start building a model (of the train-
ing set) with the shortest k-mers and attempt to include
longer words whenever there are ‘enough’ occurrences of
the word in the training data. This is the key idea in the
statistical model we adopt here: a kth order IMM (25),
which is a mixture of Markov models of all orders up to
order k. As in a ﬁxed order Markov chain, the IMM
computes the probability of generating a sequence by
multiplying the probabilities of each character (nucleotide)
given the characters before it. However, instead of condi-
tioning on a ﬁxed number (say, k) of previous characters,
the probability is calculated separately by looking at 1,
2,...k previous characters, and a linear combination of
these probabilities is the multiplicative factor contributed
by the current character (See Materials and methods
section).
We train two 5
th order IMMs, one on the training set
(‘positive’ model) and one on suitably chosen non-CRM
or ‘background’ sequences (‘negative’ model), and score
every candidate sequence by calculating the (log)-likeli-
hood ratio between two models. A positive score means
that the candidate sequence is more likely to have been
generated by (i.e. is more similar to) the positive model.
This score is henceforth called the IMM score.
Exploiting multi-species sequence data
Functional binding sites are known to be under evolution-
ary constraints, a fact that can be used to guide the search
for potential CRMs (32). As a simple implementation of
this idea, we trained the IMM using training CRMs from
D. melanogaster as well as their orthologs from 10 other
Drosophila genomes. The log-likelihood ratio score
derived from the model(s) trained in this manner is hence-
forth called the multi-species IMM (msIMM) score. Note
that this approach does not use alignment information
except when determining the boundaries of the orthologs
of a training CRM. That is, it does not rely upon align-
ments of orthologous CRMs, and thus it is free from arti-
facts of potential errors in such alignments. Evolutionary
comparison in this manner also provides a natural way to
‘smooth’ the counts of k-mers, as explained next. Binding
sites are known to be variable, yet standard Markov
chains as well as the IMM use counts of exact matches
to a k-mer to quantify the importance of that k-mer in the
generative model. Previous methods have attempted to
address this issue by allowing for a small number (e.g. 1)
of mismatches to the word in counting its occurrence—a
strategy that is rather simplistic in its modeling of binding
site variability. Examining many orthologs of a CRM
provides a natural way to capture the variability of
binding sites, to be used in training a model.
Evaluation methodology
Given a set of CRM predictions genome wide, the deﬁni-
tive test of their accuracy would be to determine experi-
mentally if each CRM drives an expression pattern in the
expected tissue and/or developmental stage. Since such
tests are typically not performed en masse (due to resource
limitations), we need an in silico evaluation strategy. In
our previous work, we proposed the following strategy,
which exploits existing databases of expression pattern
annotation across thousands of genes in D. melanogaster
(33) [BDGP (http://www.fruitﬂy.org)]. It is possible to
obtain, for any given training set T, a corresponding set
GE of genes with expression patterns similar to those of
T. Successful CRM prediction (by both criteria described
in ‘Introduction’ section) implies that CRMs predicted
using the training set T regulate genes with similar expres-
sion patterns, i.e. the predictions would be overrepre-
sented in the control regions of genes in GE. In other
words, if we consider the CRM predictions for the training
set T, and denote the set of ‘corresponding’ genes (e.g.
closest neighbors) as GT, we could use the statistical sig-
niﬁcance of the overlap between GT (the ‘predicted gene
set’) and GE (the ‘expression gene set’) as an assessment of
prediction accuracy (Figure 1A). This approach to evaluat-
ing CRM prediction has been used by several groups pre-
viously (20,22,32,34) and is a natural option to adopt
when the existing knowledge of functional CRMs in a
regulatory network is sparse, yet gene expression data-
bases are available (see Methods in Supplementary
Data, Notes 1 and 2 for more details). We evaluated the
msIMM score in this manner, using the LLHT for statis-
tical assessment of enrichment. This is a generalization of
the widely used Hypergeometric test, which we designed
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between two gene sets (see ‘Materials and Methods’
section; Materials in the Supplementary Data). We used
33 training sets and their corresponding expression gene
sets, collectively called ‘data sets’, from (20), based on the
REDﬂy (35), FlyBase (33) and BDGP (36) databases (see
‘Materials and Methods’ section). Figure 1 describes the
complete pipeline of supervised CRM prediction by the
IMM score and the evaluation strategy.
Evaluation results
The methods evaluated included the single and multi-
species versions of the IMM score, the three best perform-
ing methods from (20)—HexMCD [derived from (22)],
PAC-rc [derived from (29)] and HexYMF-s200-rc, as well
as a motif-based approach called Clover-ClusterBuster
(20)—that uses ‘Clover’ (37) for motif selection and
‘ClusterBuster’ (8) for scanning with selected motifs (see
Methods in Supplementary Data for more details)—and a
newer alignment-free method from (38) (henceforth called
AJTO). We also implemented a multi-species version of
HexMCD (called msHexMCD), as we had done for the
IMM score. The comparison between IMM and HexMCD
is of special interest as both are based on a Markov chain
formulation, but HexMCD uses a ﬁxed order (of 5), in
contrast to the interpolated order approach of IMM.
We obtained the ‘predicted gene set’ (GT, of size 200)
computed a P-value (LLHT based) for each method—
data set pair, henceforth called the ‘evaluation P-value’.
We then counted how many data sets (out of 33 in our
test-bed) yielded an evaluation P-value better than a
threshold, and varied this threshold. The results are
shown in Figure 2A.
. T h em s I M Ms c o r ew a sf o u n dt ob es u p e r i o rt oa l lo t h e r
methods by this criterion. For example, msIMM had an
evaluation P-value better than E-5 on eight data sets,
compared to the second best (non-IMM) method
msHexMCD for which the corresponding number was
ﬁve data sets. At E-10, the corresponding numbers were
four data sets for msIMM, one for msHexMCD and
IMM and zero for all other methods.
. The msIMM score yields clearly better results than
the single species IMM score, indicating the advan-
tage of using multi-species data in the training phase.
Figure 1. (A) General scheme for evaluation of a CRM discovery method. We ﬁrst select a set of genes from BDGP (or FlyBase) with expression
patterns commensurate with those of the CRMs in a data set. We next take the modules predicted for that data set and extract their nearest
neighboring genes (‘predicted gene set’). (In this step, we ignore predicted modules that overlap with any training CRMs.) Finally, we perform a
Hypergeometric test of enrichment between the expression gene set and the predicted gene set. (B) IMM of order n is a mixture of Markov models up
to order n. ‘0th MM’, ‘1th MM’,...,‘ nth MM’ denote Markov models of order 0, 1,..., n, respectively. !0,...,!n are the mixture weights. (C) Scorer
scores every windows of length 500bp with 50bp shift across the entire genome. In this toy example, the score of each sliding window (orange lines)
is shown as blue bar.
Nucleic Acids Research, 2011,Vol.39, No. 22 9467This trend was also seen when comparing the multi-
species version of HexMCD to the corresponding
single-species score used in (20).
. The single species IMM score was found to be superior
to the single species HexMCD score and to the other
single species scores (PAC-rc, HexYMF-s200-rc), re-
vealing the advantage of using variable length words
to model CRMs.
The AJTO method led to no data sets with evaluation
P-value<0.001. Since we have relatively little experience
as users of this software (38), we chose to exclude it from
further comparisons, to avoid making any biased infer-
ences about its accuracy.
To provide a more detailed view of the above compari-
sons, we plotted the overlap between the expression gene set
and the top k predicted genes, as a function of k (Figure 2B;
Supplementary Figure S2A and S2B), for one particular
data set (complete results in Supplementary Figure S2A).
While most methods are comparable to each other in
the high speciﬁcity range (e.g.  75 predictions), the
msIMM method distinguishes itself from the others in
the top 100–200 predictions. (Note that the set GT is of
size 200 for each method, for fair comparison above.) We
note, however, that this particular pattern of improved
performance is not common to all data sets
(Supplementary Figure S2A).
We also compared the evaluation P-value of msIMM to
the P-value of the best method reported in (20), for all 15
data sets where this evaluation was performed in (20).
These are listed in Table 1. (See Supplementary Table S3
for evaluation P-value of all methods in all data sets.) In
every data set, the msIMM P-value is better than or similar
to that of the competing method, with the most dramatic
improvements observed in the data sets ‘cns.1’ (E-5 to
E-9), ‘imaginal_disc.1’ (E-6 to E-11) and ‘ventral_
ectoderm.1’ (E-4 to E-12).
In the above presentation, a method’s performance is
assessed based on the overlap between the predicted gene
set (200 genes with the strongest predicted CRMs in their
control regions) and the expression gene set (see Methods
in Supplementary Data, Note 1). We also examined the
entire distribution of a method’s score for each gene in the
expression gene set and compared it to the score distribu-
tion from a random collection of genomic segments (with
lengths matching the gene control regions). These two dis-
tributions were compared using a Wilcoxon rank sum test,
and the resulting P-value indicates how well the particular
score discriminates the expression gene set (which should
have CRMs) from the randomly chosen segments (which
should only have coincidental occurrences of CRMs). The
P-values are shown for each data set and each method in
Table 2. It is clear from this evaluation that the msIMM
Figure 2. Evaluation of methods. For each method, shown is (A) the
number of data sets for which the evaluation P-value is signiﬁcant at
different LLHT P-value thresholds. For clarity, all single species
methods are formatted as dashed lines and the two multi-species
methods are shown as solid line. (B) Y-axis shows the number of
overlaps between the expression gene set and the top k predicted
genes for ‘imaginal_disc.2’ data set. (See Supplementary Figure S2A
and S2B for all other data sets.).
Table 1. Comparison between evaluation P-values of msIMM and
the best method from (20), for the 15 data sets that were
reported on by (20)
Data set Universe
size
Expression
set size
Kantorovitz
et al. (2009)
msIMM
blastoderm.1 5506 206 2E-10 5E-13
cardiac_mesoderm.1 5506 162 3E-01 5E-02
cns.1 5506 839 3E-05 6E-09
eye.1 13155 73 3E-01 6E-02
imaginal_disc.1 13155 312 3E-06 9E-11
mesectoderm.1 5506 93 3E-01 2E-03
mesoderm.1 5506 764 3E-05 6E-04
neuroectoderm.1 13155 59 1E-04 1E-04
pns.1 5506 96 8E-02 1E-02
somatic_muscle.1 13155 76 8E-01 3E-02
ventral_ectoderm.1 5506 326 8E-04 2E-12
visceral_mesoderm.1 5506 133 1E-02 5E-03
ectoderm.2 5506 834 4E-03 1E-05
neuronal.2 5506 66 3E-03 8E-02
wing.2 13155 135 2E-03 3E-06
The second and third columns show the total number of genes in the
expression data source and the size of expression gene set for each data
set, respectively (the size of the predicted gene set is 200 for all data
sets). The lowest (best) P-value for each pair is shaded. Note that the
P-values reported here are LLHT P-values, which are different from
the standard Hypergeometric P-values shown in Table 2 of (20).
9468 Nucleic Acids Research, 2011,Vol.39, No. 22score is best able to discriminate between the expression
gene set and the random set, for the most number of data
sets.
Experimental validation
We chose 12 putative CRMs predicted using the ‘meso-
derm’ and ‘somatic muscle’ training sets (six for each), and
tested them for regulatory activity in vivo. These two data
sets were chosen partly because their evaluation P-values
were signiﬁcant but not among the best. (This is especially
true for the ‘somatic muscle’ set; evaluation P=0.03.)
Unlike (20), where the tested CRMs were from the data
set with the strongest evaluation P-value (‘blastoderm’,
P=5E-13), our goal here was to investigate the effective-
ness of our methods in what seem to be more challenging
data sets. We also note that these two data sets are not
exclusive from other data sets (e.g. ‘visceral mesoderm’) in
terms of their deﬁning expression patterns, which creates
additional difﬁculties for supervised CRM discovery.
The 12 candidate CRMs were selected by the following
criteria:
(1) they are located near genes in the respective expres-
sion gene set;
(2) they collectively fall across the spectrum of msIMM
scores, allowing us to examine (through direct experi-
mental assays) the accuracy of this new scoring sc-
heme not just at its highest scoring predictions but
also at the medium and low scoring predictions; and
(3) each candidate scores well by either msIMM or PAC-
rc, i.e. a candidate with a relatively low msIMM score
(<0) has some supporting evidence in favor of it
being a potential CRM.
Figure 3 summarizes the results of our experiments. Of
the 12 tested sequences, 10 (83%) were found to drive re-
porter gene expression in a tissue- or stage-speciﬁc pattern
(see Methods in Supplementary Data, Note 3). The two
failed predictions (corresponding to genes tkv and tsh)w e r e
the two lowest scoring predictions of msIMM (in this set).
Table 2. Discrimination between control regions of an expression gene set and random sequences of matching lengths
Data set CRM
set size
Expression
set size
Clover-
ClusterBuster
PAC-rc HexYMF-
s200-rc
HexMCD msHexMCD IMM msIMM
adult_mesoderm.1 5 56 0.0731 9E-06 0.0003 0.0004 7E-06 6E-06 0.0002
amnioserosa.1 7 126 0.0002 6E-10 6E-08 5E-17 2E-10 6E-12 3E-15
blastoderm.1 77 206 6E-20 4E-34 2E-31 7E-44 1E-42 1E-50 9E-51
cardiac_mesoderm.1 8 162 0.0001 1E-05 1E-05 4E-19 7E-13 5E-20 2E-22
cns.1 34 839 7E-30 7E-17 1E-12 6E-54 5E-41 2E-82 2E-63
dorsal_ectoderm.1 8 640 6E-29 9E-28 4E-17 4E-56 7E-47 3E-58 1E-67
ectoderm.1 37 109 5E-12 2E-19 1E-11 1E-18 1E-17 6E-19 8E-19
endoderm.1 16 195 6E-06 4E-13 4E-09 7E-27 3E-20 5E-24 4E-22
eye.1 6 73 8E-05 0.0012 0.016 2E-07 3E-05 5E-06 1E-07
fat_body.1 5 61 1 0.0014 0.0025 3E-09 5E-08 6E-08 3E-08
female_gonad.1 10 237 0.0015 0.0545 0.0098 7E-16 5E-07 2E-32 8E-39
glia.1 7 44 0.0031 5E-07 2E-05 2E-07 5E-06 4E-06 4E-06
imaginal_disc.1 47 312 8E-13 7E-27 7E-24 4E-25 9E-28 2E-39 1E-40
male_gonad.1 8 237 1 0.3967 0.2561 7E-16 5E-07 2E-32 8E-39
malpighian_tubules.1 4 9 0.0491 0.0003 0.0459 0.2022 0.0169 0.0093 0.0354
mesectoderm.1 5 93 2E-05 8E-10 1E-07 5E-17 3E-16 1E-15 8E-15
mesoderm.1 16 764 0.1972 0.0178 0.1324 3E-47 7E-30 3E-126 4E-142
neuroectoderm.1 7 59 2E-06 9E-12 2E-12 9E-07 2E-15 4E-10 6E-09
pns.1 24 96 0.0003 3E-07 2E-05 6E-08 4E-07 1E-10 8E-10
salivary_gland.1 6 123 0.0663 0.0084 0.003 6E-10 5E-05 4E-06 1E-10
somatic_muscle.1 12 76 0.0023 2E-07 0.0002 8E-11 3E-09 5E-11 5E-12
tracheal_system.1 9 355 6E-12 1E-21 3E-19 4E-25 3E-16 3E-32 2E-25
ventral_ectoderm.1 12 326 2E-22 1E-14 1E-12 5E-40 2E-33 1E-42 1E-47
visceral_mesoderm.1 12 133 2E-06 5E-08 1E-05 1E-18 7E-15 7E-16 1E-18
ectoderm.2 51 834 2E-43 2E-43 2E-29 4E-77 4E-62 1E-98 3E-83
eye.2 18 153 2E-05 4E-13 1E-11 3E-15 3E-16 8E-17 3E-19
imaginal_disc.2 12 312 1 8E-17 2E-17 9E-26 8E-28 9E-30 2E-36
mesoderm.2 45 764 3E-07 0.0006 0.059 3E-47 3E-30 7E-95 1E-66
neuronal.2 54 66 0.0002 0.0053 0.0187 4E-05 0.0003 8E-05 3E-05
reproductive_system.2 21 421 5E-09 8E-05 1E-04 4E-21 1E-12 2E-35 2E-26
wing.2 33 135 2E-05 3E-14 4E-11 4E-15 8E-15 4E-19 3E-19
adult.3 34 394 2E-13 2E-22 4E-18 2E-30 1E-25 6E-33 3E-30
larva.3 69 743 3E-37 4E-61 3E-53 7E-78 2E-68 3E-85 2E-80
Number of ‘wins’ 0 2 0 5 1 9 16
The second and third columns show the number of training CRMs and the size of expression gene set, respectively, for each data set. Scores of genes
in an expression gene set were compared to scores of a collection of randomly chosen genomic regions. The score of a sequence is the maximum score
in that region, under a CRM prediction scheme. For each gene in the expression gene set, 50 random genomic segments of length equal to the gene’s
territory length were included in the random collection. The last seven columns show the P-values (Wilcoxon rank sum test) of such a comparison for
each data set and for each method. The best P-value for each data set is shaded. The last row indicates the number of times that a method is superior
(smallest P-value).
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Figure 3. In vivo validation of 12 Drosophila CRM predictions. Transgenic embryos were stained with antibodies to GFP to detect reporter gene
expression. Embryos are oriented anterior to the left. Panels A, F, G, K, M, O and S are dorsal views; H and N are ventral views; the remainder are
lateral views with dorsal to the top. ‘Pattern-speciﬁc’ CRMs are shown in panels A–L and non-pattern speciﬁc CRMs in panels M–T. (A) The
Antp_161 CRM drives expression in several tissues, including the visceral mesoderm (arrowhead) and the non-mesodermal midgut (asterisk). The
endogenous Antp gene is expressed in a much more restricted manner, suggesting that the reporter gene expression is either ectopic or that the CRM
is associated with a different gene of undetermined identity. (B) Co-labeling for Tropomyosin (magenta) shows GFP expression (green) in somatic
muscles, in particular the lateral transverse muscle ﬁbers (arrowheads). (C and D) The how_171 CRM drives expression in the mesoderm in both
mid-stage (C) and late-stage (D) embryos, consistent with how gene expression. (E–H) The noc_532 CRM is active in many noc-positive tissues
throughout embryogenesis. Pictured is metameric expression in both ectoderm and mesoderm at stage 9 (E), in the visceral mesoderm (F, arrow-
head), in the mesodermally-derived lymph glands (G, arrowhead), the ventral nerve cord (H, arrow) and the hindgut (H, arrowhead). (I) Mhc_537
regulates reporter gene expression (green) in a subset of Mhc-positive mesodermal cells including longitudinal visceral muscles (arrow) and several
ventral oblique somatic muscle ﬁbers (arrowheads). (J) Longitudinal visceral muscle precursors express GFP under the control of the slou_847 CRM
(arrowheads), cells not positive for endogenous slou expression. Expression is also observed in the supraesophogeal ganglion (K) and ventral nerve
cord (data not shown), consistent with known slou expression patterns. Inset shows a more dorsal view of the anterior portion of the embryo in the
main panel. (L) mbc_64 drives expression in the mbc-positive mesoderm, pictured here at stage 16. (M and N). Expression driven by the lola_648
CRM is conﬁned to the central nervous system in both mid-stage (M) and late-stage (N) embryos, consistent with lola expression. lola_648 overlaps
the independently discovered CRM40 of (40). (O) The slou-828 CRM regulates reporter gene expression in tissues that are not slou-positive including
cells in the antenno-maxillary complex (black arrow), the posterior spiracles (arrowhead) and cells in the anterior and posterior portions of the
foregut (white arrow and data not shown). (P) slou_828-controlled expression is also observed in the midgut, consistent with normal slou expression.
(Q and R) The rib_120 CRM drives expression throughout hindgut development, part of the normal rib expression pattern. (S and T) Reporter gene
expression regulated by the ama_299 CRM is restricted to the central nervous system. Although ama is not expressed in the CNS of late-stage
embryos (41), earlier expression in the ventral midline beginning at stage 8 (data not shown) is consistent with ama expression at that stage.
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(continued)We then examined the two speciﬁc success criteria we laid
down in the beginning (‘Introduction’ section). Due to the
non-exclusive and overlapping nature of the expression
patterns found within each of the two training sets, we
considered any mesodermal gene expression as matching
the training pattern. Of the 12 tested sequences (50%), 6
showed reporter gene expression in one or more mesoder-
mal tissues (Figure 3A–L). Remarkably, the msIMM
score was able to predict success by this criterion with
90% accuracy. In particular, a threshold value of the
msIMM score was able to separate the pattern-speciﬁc
CRMs from the non-speciﬁc CRMs (or non-CRMs)
with only one false positive error (Figure 3U). Of the 12
predicted CRMs, 10 (83%) drive an expression pattern
matching at least in part that of the endogenous expres-
sion of the nearest gene.
Visualization tool
In addition to making the source code directly available
for download, we have developed a plugin for Gbrowse
(39), called ‘Supervised CRM discovery’, through which
the user can select a set of related CRMs as their starting
point and browse a genomic region of interest for other
putative CRMs with similar functionality. The plugin can
be accessed via: http://veda.cs.uiuc.edu/gs.
CONCLUSION
We have presented a new statistical method for genome-
wide prediction of CRMs, beginning with a collection of
known modules in the regulatory network of interest. This
problem of ‘supervised CRM prediction’ was visited in
our previous work (20), where we established the neces-
sary benchmarks and evaluation methodology, and also
compiled a suite of pre-existing and novel methods to
solve the problem. The new method we propose now is
shown to be superior to the best of the methods con-
sidered in (20), hence advancing the state of the art on
this important topic.
Our work makes three additional regulatory
networks—central nervous system, imaginal disc and
ventral ectoderm—amenable to supervised CRM predic-
tion. Our experiments also contribute 10 new CRMs,
involved in development of early mesoderm and of
somatic muscle, to the literature.
Our new method, along with our previously compiled
techniques (20), represents a ﬂexible, accurate way of iden-
tifying regulatory sequences, especially for less fully
described processes for which we lack the knowledge of
relevant transcription factors. It can prove to be an im-
portant in silico adjunct to and extension of empirical
CRM discovery approaches. Furthermore, it has the po-
tential to lead to novel CRM predictions in experimentally
less well-characterized arthropods such as mosquito,
wasp, beetle and honeybee, while exploiting existing col-
lections of CRMs in Drosophila.
We have also made a key improvement to the evalu-
ation methodology for genome-wide CRM prediction
methods, by proposing the locus LLHT. This new test is
shown to lead to superior speciﬁcity (lower false positive
rate) when enrichment tests are performed with gene sets
of unusually large locus lengths. The Hypergeometric test
of signiﬁcance of overlap between gene sets forms the basis
of many tools used in genomics, and the common phe-
nomenon of locus length variability therefore casts
doubts on the statistical inferences from these tools (26).
Our modiﬁcation to the Hypergeometric test (LLHT) thus
has the potential of widespread usability in contexts
beyond CRM discovery.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
FUNDING
Funding for open access charge: National Institutes of
Health (1R01GM085233-01 to S.S. and M.S.H.).
Conﬂict of interest statement. None declared.
REFERENCES
1. Davidson,E.H. (2001) Genomic Regulatory Systems, 1 edn.
Academic Press, San Diego.
2. Davidson,E.H. (2006) The Regulatory Genome: Gene Regulatory
Networks in Development and Evolution, 1st edn. Academic Press,
Burlington, MA.
3. Xi,H., Yu,Y., Fu,Y., Foley,J., Halees,A. and Weng,Z. (2007)
Analysis of overrepresented motifs in human core promoters
reveals dual regulatory roles of YY1. Genome Res., 17, 798–806.
4. Li,X.Y., MacArthur,S., Bourgon,R., Nix,D., Pollard,D.A.,
Iyer,V.N., Hechmer,A., Simirenko,L., Stapleton,M., Luengo
Hendriks,C.L. et al. (2008) Transcription factors bind thousands
of active and inactive regions in the Drosophila blastoderm.
PLoS Biol., 6, e27.
5. Visel,A., Blow,M.J., Li,Z., Zhang,T., Akiyama,J.A., Holt,A.,
Plajzer-Frick,I., Shoukry,M., Wright,C., Chen,F. et al. (2009)
ChIP-seq accurately predicts tissue-speciﬁc activity of enhancers.
Nature, 457, 854–858.
6. Berman,B.P., Nibu,Y., Pfeiffer,B.D., Tomancak,P., Celniker,S.E.,
Levine,M., Rubin,G.M. and Eisen,M.B. (2002) Exploiting
transcription factor binding site clustering to identify
cis-regulatory modules involved in pattern formation in the
Drosophila genome. Proc. Natl Acad. Sci. USA, 99, 757–762.
7. Halfon,M.S., Grad,Y., Church,G.M. and Michelson,A.M. (2002)
Computation-based discovery of related transcriptional regulatory
Figure 3. Continued
(U) Summary of results and msIMM scores for each predicted CRM. Names are based on the closest gene to each predicted module and do not
necessarily reﬂect the actual gene regulated by the CRM. ‘Data set’ indicates the data set from which the CRM was predicted (‘S’ and ‘M’ for
somatic muscle and mesoderm respectively). ‘Pattern?’ indicates whether the tested sequence drives a spatial and/or temporal expression pattern.
‘Matches training set?’ and ‘Matches gene?’ indicate whether the expression pattern agrees with that of the training set or the nearest gene,
respectively. Check marks/blue coloring denote a positive result, crosses and yellow coloring a negative result. Mixed blue and yellow coloring is
used for cases where both endogenous and ectopic gene expression patterns are observed. ‘Score’ shows msIMM scores for each tested CRM. The
gray arrow points to the best decision stump on msIMM scores in terms of predicting pattern-speciﬁc CRMs.
Nucleic Acids Research, 2011,Vol.39, No. 22 9471modules and motifs using an experimentally validated
combinatorial model. Genome Res., 12, 1019–1028.
8. Frith,M.C., Li,M.C. and Weng,Z. (2003) Cluster-Buster: Finding
dense clusters of motifs in DNA sequences. Nucleic Acids Res.,
31, 3666–3668.
9. Sinha,S., van Nimwegen,E. and Siggia,E.D. (2003) A probabilistic
method to detect regulatory modules. Bioinformatics, 19(Suppl. 1),
i292–i301.
10. Philippakis,A.A., He,F.S. and Bulyk,M.L. (2005) Moduleﬁnder: a
tool for computational discovery of cis regulatory modules.
Pac. Symp. Biocomput., 10, 519–530.
11. Donaldson,I.J., Chapman,M. and Gottgens,B. (2005)
TFBScluster: a resource for the characterization of transcriptional
regulatory networks. Bioinformatics, 21, 3058–3059.
12. Bryne,J.C., Valen,E., Tang,M.H., Marstrand,T., Winther,O., da
Piedade,I., Krogh,A., Lenhard,B. and Sandelin,A. (2008)
JASPAR, the open access database of transcription factor-binding
proﬁles: new content and tools in the 2008 update. Nucleic Acids
Res., 36, D102–D106.
13. Wingender,E., Dietze,P., Karas,H. and Knuppel,R. (1996)
TRANSFAC: a database on transcription factors and their DNA
binding sites. Nucleic Acids Res., 24, 238–241.
14. Bergman,C.M., Carlson,J.W. and Celniker,S.E. (2005) Drosophila
DNase I footprint database: a systematic genome annotation of
transcription factor binding sites in the fruitﬂy, Drosophila
melanogaster. Bioinformatics, 21, 1747–1749.
15. Berger,M.F., Philippakis,A.A., Qureshi,A.M., He,F.S.,
Estep,P.W. 3rd and Bulyk,M.L. (2006) Compact, universal DNA
microarrays to comprehensively determine transcription-factor
binding site speciﬁcities. Nat. Biotechnol., 24, 1429–1435.
16. Zhu,L.J., Christensen,R.G., Kazemian,M., Hull,C.J.,
Enuameh,M.S., Basciotta,M.D., Braseﬁeld,J.A., Zhu,C.,
Asriyan,Y., Lapointe,D.S. et al. (2011) FlyFactorSurvey: a
database of Drosophila transcription factor binding speciﬁcities
determined using the bacterial one-hybrid system. Nucleic Acids
Res., 39, D111–D117.
17. Tompa,M., Li,N., Bailey,T.L., Church,G.M., De Moor,B.,
Eskin,E., Favorov,A.V., Frith,M.C., Fu,Y., Kent,W.J. et al.
(2005) Assessing computational tools for the discovery of
transcription factor binding sites. Nat Biotechnol, 23, 137–144.
18. Hu,J., Li,B. and Kihara,D. (2005) Limitations and potentials of
current motif discovery algorithms. Nucleic Acids Res., 33,
4899–4913.
19. Sandve,G.K., Abul,O., Walseng,V. and Drablos,F. (2007)
Improved benchmarks for computational motif discovery.
BMC Bioinformatics, 8, 193.
20. Kantorovitz,M.R., Kazemian,M., Kinston,S., Miranda-
Saavedra,D., Zhu,Q., Robinson,G.E., Gottgens,B., Halfon,M.S.
and Sinha,S. (2009) Motif-blind, genome-wide discovery of
cis-regulatory modules in Drosophila and mouse. Dev. Cell, 17,
568–579.
21. Chan,B.Y. and Kibler,D. (2005) Using hexamers to predict
cis-regulatory motifs in Drosophila. BMC Bioinformatics, 6, 262.
22. Grad,Y.H., Roth,F.P., Halfon,M.S. and Church,G.M. (2004)
Prediction of similarly acting cis-regulatory modules by
subsequence proﬁling and comparative genomics in Drosophila
melanogaster and D.pseudoobscura. Bioinformatics, 20,
2738–2750.
23. Narlikar,L., Sakabe,N.J., Blanski,A.A., Arimura,F.E.,
Westlund,J.M., Nobrega,M.A. and Ovcharenko,I. (2010)
Genome-wide discovery of human heart enhancers. Genome Res.,
20, 381–392.
24. Ivan,A., Halfon,M.S. and Sinha,S. (2008) Computational
discovery of cis-regulatory modules in Drosophila without prior
knowledge of motifs. Genome Biol., 9, R22.
25. Salzberg,S.L., Delcher,A.L., Kasif,S. and White,O. (1998)
Microbial gene identiﬁcation using interpolated Markov models.
Nucleic Acids Res., 26, 544–548.
26. Taher,L. and Ovcharenko,I. (2009) Variable locus length in the
human genome leads to ascertainment bias in functional inference
for non-coding elements. Bioinformatics, 25, 578–584.
27. Gallo,S.M., Gerrard,D.T., Miner,D., Simich,M., Des Soye,B.,
Bergman,C.M. and Halfon,M.S. (2011) REDﬂy v3.0: toward a
comprehensive database of transcriptional regulatory elements in
Drosophila. Nucleic Acids Res., 39, D118–D123.
28. Kantorovitz,M.R., Robinson,G.E. and Sinha,S. (2007) A
statistical method for alignment-free comparison of regulatory
sequences. Bioinformatics, 23, i249–i255.
29. van Helden,J. (2004) Metrics for comparing regulatory sequences
on the basis of pattern counts. Bioinformatics, 20, 399–406.
30. Vinga,S. and Almeida,J. (2003) Alignment-free sequence
comparison-a review. Bioinformatics, 19, 513–523.
31. Leung,G. and Eisen,M.B. (2009) Identifying cis-regulatory
sequences by word proﬁle similarity. PLoS ONE, 4, e6901.
32. Sinha,S., Schroeder,M.D., Unnerstall,U., Gaul,U. and Siggia,E.D.
(2004) Cross-species comparison signiﬁcantly improves
genome-wide prediction of cis-regulatory modules in Drosophila.
BMC Bioinformatics, 5, 129.
33. Tweedie,S., Ashburner,M., Falls,K., Leyland,P., McQuilton,P.,
Marygold,S., Millburn,G., Osumi-Sutherland,D., Schroeder,A.,
Seal,R. et al. (2009) FlyBase: enhancing Drosophila Gene
Ontology annotations. Nucleic Acids Res., 37, D555–D559.
34. Pennacchio,L.A., Loots,G.G., Nobrega,M.A. and Ovcharenko,I.
(2007) Predicting tissue-speciﬁc enhancers in the human genome.
Genome Res., 17, 201–211.
35. Halfon,M.S., Gallo,S.M. and Bergman,C.M. (2008) REDﬂy 2.0:
an integrated database of cis-regulatory modules and transcription
factor binding sites in Drosophila. Nucleic Acids Res., 36,
D594–D598.
36. Tomancak,P., Berman,B.P., Beaton,A., Weiszmann,R., Kwan,E.,
Hartenstein,V., Celniker,S.E. and Rubin,G.M. (2007) Global
analysis of patterns of gene expression during Drosophila
embryogenesis. Genome Biol., 8, R145.
37. Frith,M.C., Fu,Y., Yu,L., Chen,J.F., Hansen,U. and Weng,Z.
(2004) Detection of functional DNA motifs via statistical
over-representation. Nucleic Acids Res., 32, 1372–1381.
38. Arunachalam,M., Jayasurya,K., Tomancak,P. and Ohler,U. (2010)
An alignment-free method to identify candidate orthologous
enhancers in multiple Drosophila genomes. Bioinformatics, 26,
2109–2115.
39. Stein,L.D., Mungall,C., Shu,S., Caudy,M., Mangone,M., Day,A.,
Nickerson,E., Stajich,J.E., Harris,T.W., Arva,A. et al. (2002) The
generic genome browser: a building block for a model organism
system database. Genome Res., 12, 1599–1610.
40. Rouault,H., Mazouni,K., Couturier,L., Hakim,V. and
Schweisguth,F. (2010) Genome-wide identiﬁcation of
cis-regulatory motifs and modules underlying gene coregulation
using statistics and phylogeny. Proc. Natl Acad. Sci. USA, 107,
14615–14620.
41. Fremion,F., Darboux,I., Diano,M., Hipeau-Jacquotte,R.,
Seeger,M.A. and Piovant,M. (2000) Amalgam is a ligand for the
transmembrane receptor neurotactin and is required for
neurotactin-mediated cell adhesion and axon fasciculation in
Drosophila. EMBO J., 19, 4463–4472.
9472 Nucleic Acids Research, 2011,Vol.39, No. 22